Does LORAZEPAM Cause Neuroblastoma recurrent? 17 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 17 reports of Neuroblastoma recurrent have been filed in association with LORAZEPAM (Lorazepam). This represents 0.1% of all adverse event reports for LORAZEPAM.
17
Reports of Neuroblastoma recurrent with LORAZEPAM
0.1%
of all LORAZEPAM reports
17
Deaths
0
Hospitalizations
How Dangerous Is Neuroblastoma recurrent From LORAZEPAM?
Of the 17 reports, 17 (100.0%) resulted in death.
Is Neuroblastoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LORAZEPAM. However, 17 reports have been filed with the FAERS database.
What Other Side Effects Does LORAZEPAM Cause?
Drug ineffective (3,775)
Drug abuse (3,741)
Toxicity to various agents (2,836)
Completed suicide (2,340)
Off label use (2,178)
Somnolence (2,114)
Sopor (2,042)
Anxiety (1,573)
Fall (1,524)
Overdose (1,516)
What Other Drugs Cause Neuroblastoma recurrent?
DINUTUXIMAB (76)
TEMOZOLOMIDE (28)
IRINOTECAN (27)
CYCLOPHOSPHAMIDE (26)
FILGRASTIM (23)
PEGFILGRASTIM (23)
TECELEUKIN (21)
DEXAMETHASONE (18)
LORLATINIB (18)
METHADONE (18)
Which LORAZEPAM Alternatives Have Lower Neuroblastoma recurrent Risk?
LORAZEPAM vs LORCASERIN
LORAZEPAM vs LORLATINIB
LORAZEPAM vs LORMETAZEPAM
LORAZEPAM vs LORNOXICAM
LORAZEPAM vs LOSARTAN